MEDICAMEN BIOTECH
|
MEDICAMEN BIOTECH Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity - Authorised | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr | ₹15 Cr |
Equity - Issued | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity Paid Up | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr | ₹12 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹181 Cr | ₹134 Cr | ₹121 Cr | ₹109 Cr | ₹75 Cr |
Securities Premium | ₹98 Cr | ₹68 Cr | ₹68 Cr | ₹68 Cr | ₹43 Cr |
Capital Reserves | ₹-2.37 Cr | ₹-2.23 Cr | ₹-2.14 Cr | ₹-2.29 Cr | - |
Profit & Loss Account Balance | ₹82 Cr | ₹69 Cr | ₹55 Cr | ₹44 Cr | ₹32 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹2.61 Cr | - | - | - | - |
Reserve excluding Revaluation Reserve | ₹181 Cr | ₹134 Cr | ₹121 Cr | ₹109 Cr | ₹75 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹193 Cr | ₹146 Cr | ₹133 Cr | ₹121 Cr | ₹87 Cr |
Minority Interest | ₹0.12 Cr | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹0.87 Cr | ₹5.07 Cr | ₹6.41 Cr | ₹2.36 Cr | ₹0.02 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹1.38 Cr | ₹6.50 Cr | ₹7.82 Cr | ₹2.29 Cr | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-0.51 Cr | ₹-1.43 Cr | ₹-1.42 Cr | ₹0.07 Cr | ₹0.02 Cr |
Unsecured Loans | - | - | - | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-1.88 Cr | ₹-0.50 Cr | ₹0.28 Cr | ₹0.16 Cr | ₹0.41 Cr |
Deferred Tax Assets | ₹0.63 Cr | ₹0.67 Cr | ₹0.53 Cr | - | - |
Deferred Tax Liability | ₹-1.25 Cr | ₹0.17 Cr | ₹0.81 Cr | ₹0.16 Cr | ₹0.41 Cr |
Other Long Term Liabilities | - | - | - | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹1.66 Cr | ₹1.46 Cr | ₹1.16 Cr | ₹1.06 Cr | ₹0.98 Cr |
Total Non-Current Liabilities | ₹0.65 Cr | ₹6.04 Cr | ₹7.84 Cr | ₹3.58 Cr | ₹1.42 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹48 Cr | ₹43 Cr | ₹32 Cr | ₹37 Cr | ₹31 Cr |
Sundry Creditors | ₹48 Cr | ₹43 Cr | ₹32 Cr | ₹37 Cr | ₹31 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹7.29 Cr | ₹5.03 Cr | ₹4.90 Cr | ₹5.91 Cr | ₹0.78 Cr |
Bank Overdraft / Short term credit | ₹3.94 Cr | ₹2.00 Cr | - | - | - |
Advances received from customers | - | - | - | - | - |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹3.34 Cr | ₹3.03 Cr | ₹4.90 Cr | ₹5.91 Cr | ₹0.78 Cr |
Short Term Borrowings | ₹23 Cr | ₹19 Cr | ₹11 Cr | ₹7.62 Cr | ₹12 Cr |
Secured ST Loans repayable on Demands | ₹23 Cr | ₹19 Cr | ₹11 Cr | ₹7.62 Cr | ₹12 Cr |
Working Capital Loans- Sec | ₹23 Cr | ₹19 Cr | ₹11 Cr | ₹7.62 Cr | ₹12 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-23 Cr | ₹-19 Cr | ₹-11 Cr | ₹-7.62 Cr | ₹-12 Cr |
Short Term Provisions | ₹4.39 Cr | ₹5.09 Cr | ₹5.23 Cr | ₹5.57 Cr | ₹5.58 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹3.70 Cr | ₹4.26 Cr | ₹4.60 Cr | ₹4.94 Cr | ₹5.33 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹0.69 Cr | ₹0.82 Cr | ₹0.63 Cr | ₹0.63 Cr | ₹0.26 Cr |
Total Current Liabilities | ₹83 Cr | ₹73 Cr | ₹53 Cr | ₹56 Cr | ₹49 Cr |
Total Liabilities | ₹277 Cr | ₹225 Cr | ₹194 Cr | ₹181 Cr | ₹137 Cr |
ASSETS | |||||
Gross Block | ₹130 Cr | ₹124 Cr | ₹116 Cr | ₹58 Cr | ₹47 Cr |
Less: Accumulated Depreciation | ₹38 Cr | ₹32 Cr | ₹26 Cr | ₹24 Cr | ₹22 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹93 Cr | ₹92 Cr | ₹90 Cr | ₹34 Cr | ₹24 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | ₹40 Cr | ₹15 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹1.11 Cr | ₹0.87 Cr | ₹0.78 Cr | ₹0.63 Cr | ₹0.58 Cr |
Other Non Current Assets | ₹12 Cr | ₹1.08 Cr | ₹0.90 Cr | ₹0.29 Cr | ₹0.29 Cr |
Total Non-Current Assets | ₹106 Cr | ₹94 Cr | ₹91 Cr | ₹75 Cr | ₹40 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Inventories | ₹45 Cr | ₹27 Cr | ₹5.20 Cr | ₹17 Cr | ₹15 Cr |
Raw Materials | ₹18 Cr | ₹12 Cr | ₹1.80 Cr | ₹8.28 Cr | ₹8.39 Cr |
Work-in Progress | ₹0.90 Cr | ₹1.16 Cr | ₹0.52 Cr | ₹0.85 Cr | ₹0.69 Cr |
Finished Goods | ₹17 Cr | ₹5.22 Cr | ₹2.51 Cr | ₹3.23 Cr | ₹1.86 Cr |
Packing Materials | ₹8.66 Cr | ₹8.80 Cr | ₹0.18 Cr | ₹4.43 Cr | ₹4.22 Cr |
Stores Ā and Spare | ₹0.42 Cr | ₹0.25 Cr | ₹0.19 Cr | ₹0.18 Cr | ₹0.10 Cr |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹65 Cr | ₹63 Cr | ₹53 Cr | ₹50 Cr | ₹43 Cr |
Debtors more than Six months | ₹13 Cr | ₹15 Cr | ₹8.40 Cr | ₹9.38 Cr | ₹7.67 Cr |
Debtors Others | ₹53 Cr | ₹48 Cr | ₹44 Cr | ₹41 Cr | ₹36 Cr |
Cash and Bank | ₹21 Cr | ₹3.83 Cr | ₹3.89 Cr | ₹3.09 Cr | ₹8.52 Cr |
Cash in hand | ₹0.01 Cr | ₹0.02 Cr | ₹0.01 Cr | ₹0.03 Cr | ₹0.07 Cr |
Balances at Bank | ₹21 Cr | ₹3.81 Cr | ₹3.88 Cr | ₹3.06 Cr | ₹8.45 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹22 Cr | ₹20 Cr | ₹23 Cr | ₹22 Cr | ₹15 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹0.07 Cr | ₹0.74 Cr | ₹0.43 Cr | ₹0.44 Cr | ₹0.26 Cr |
Other current_assets | ₹22 Cr | ₹20 Cr | ₹23 Cr | ₹21 Cr | ₹14 Cr |
Short Term Loans and Advances | ₹10 Cr | ₹8.70 Cr | ₹11 Cr | ₹13 Cr | ₹14 Cr |
Advances recoverable in cash or in kind | ₹6.55 Cr | ₹4.22 Cr | ₹6.30 Cr | ₹7.63 Cr | ₹9.73 Cr |
Advance income tax and TDS | ₹3.36 Cr | ₹4.17 Cr | ₹4.73 Cr | ₹4.47 Cr | ₹4.13 Cr |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹0.31 Cr | ₹0.31 Cr | ₹0.41 Cr | ₹0.51 Cr | ₹0.55 Cr |
Total Current Assets | ₹163 Cr | ₹123 Cr | ₹96 Cr | ₹104 Cr | ₹96 Cr |
Net Current Assets (Including Current Investments) | ₹81 Cr | ₹50 Cr | ₹43 Cr | ₹48 Cr | ₹48 Cr |
Miscellaneous Expenses not written off | ₹7.06 Cr | ₹7.74 Cr | ₹6.66 Cr | ₹2.04 Cr | ₹0.42 Cr |
Total Assets | ₹277 Cr | ₹225 Cr | ₹194 Cr | ₹181 Cr | ₹137 Cr |
Contingent Liabilities | - | - | - | - | - |
Total Debt | ₹26 Cr | ₹26 Cr | ₹19 Cr | ₹11 Cr | ₹12 Cr |
Book Value | - | 113.56 | 103.33 | 97.55 | 73.69 |
Adjusted Book Value | 147.21 | 113.56 | 103.33 | 97.55 | 73.69 |
Compare Balance Sheet of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹551.3 Cr | 1.7% | -21.3% | -34% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,625.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹112,938.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹101,315.0 Cr | -1.6% | -7% | 23.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,276.9 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹93,921.9 Cr | 5% | 10.4% | 109.1% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | 1.7% |
-21.3% |
-34% |
SENSEX | 1.3% |
2.6% |
24% |
You may also like the below Video Courses